# The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body

> **NCT00910702** · EARLY_PHASE1 · COMPLETED · sponsor: **GuangZhou WeiShiBo Biotechnology Co., ltd** · enrollment: 15 (actual)

## Conditions studied

- Retinal Detachment

## Interventions

- **DEVICE:** foldable capsular vitreous body(FCVB)

## Key facts

- **NCT ID:** NCT00910702
- **Lead sponsor:** GuangZhou WeiShiBo Biotechnology Co., ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910702, "The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00910702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*